Factors associated to duration of hepatitis a outbreaks: Implications for control

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Torner, Nuria ^a,b,c   Broner, Sonia ^b   Martinez, Ana ^a   Tortajada, Cecilia ^d   de Garcia Olalla, Patricia ^b,d   Barrabeig, Irene ^a   Sala, MariaRosa ^a   Camps, Neus ^a   Minguell, Sofia ^a   Alvarez, Josep ^a   Ferrús, Gloria ^a   Torra, Roser ^a   Godoy, Pere ^a,b   Dominguez, Angela ^b,c  

^a Generalitat of Catalonia ^*  (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN M; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; DISEASE DURATION; EARLY INTERVENTION; EPIDEMIC; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INCIDENCE; INFECTION CONTROL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL; SCHOOL CHILD; SPAIN; VIRUS TRANSMISSION; BLOOD; DISEASE TRANSMISSION; FEMALE; GENETICS; HEALTH SURVEY; ISOLATION AND PURIFICATION; MALE; ORGANIZATION AND MANAGEMENT; PATHOGENICITY; RISK FACTOR; TIME;

CHILD; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; DNA, VIRAL; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS; HUMANS; MALE; POPULATION SURVEILLANCE; RISK FACTORS; SCHOOLS; SPAIN; TIME FACTORS;

EID: 84857096660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031339     Document Type: Article

References (20)

1. American Academy of Pediatrics (2007) Hepatitis A Recommendations. Pediatrics 120: 189-199.
2. Hershey JH, Schowalter L, Bailey SB, (2005) Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings. Am J Med 118: (Suppl 10A): 100S-108S.
3. Oviedo M, Munoz MP, Dominguez A, Carmona G, (2006) Estimated incidence of hepatitis A virus infection in Catalonia. Ann Epidemio 16: 812-819.
4. Dominguez A, Oviedo M, Carmona G, Batalla J, Bruguera M, et al. (2008) Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine 26: 1737-1741.
5. Craig AS, Watson B, Zink TK, Davis JP, Yu C, et al. (2007) Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease. Am J Med Sci 2007 334: 180-183.
6. Lopalco PL, Malfait P, Menniti-Ippolito F, et al. (2005) Determinants of acquiring hepatitis A virus disease in a large Italian region in endemic and epidemic periods. J Viral Hepat 12: 315-321.
7. Hosmer DS, Lemeshow S, (2000) Applied Logistic Regression. 2nd ed New York John Wyley & Sons.
8. Diel R, Schneider S, (2001) Transmission of hepatitis A in Hamburg, Germany, 1998-1999-A prospective population based study. Eur J Epidemiol 17: 175-182.
9. Adamson R, Reddy V, Jones L, Antwi M, Bregman B, et al. (2010) Epidemiology and burden of hepatitis A, malaria, and typhoid in New York City associated with travel: implications for public health policy. Am J Public Health 100: 1249-1252.
10. Steffen R, (2005) Changing travel-related global epidemiology of hepatitis. A. Am J Med 118 (Suppl 10A): 46S-49S.
11. Llach-Berne M, Panella H, Dominguez A, Cayla J, Godoy P, et al. (2006) [Descriptive study of hepatitis outbreaks occurring in Catalonia (1999-2003)]. Enferm Infecc Microbiol Clin 24: 431-436.
12. Centers for Disease Control and prevention. (2007) Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 56: 1080-1084.
13. Luyten J, Beutels P, (2009) Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A. Pharmacoeconomics 27: 379-389.
14. Craig AS, Sockwell DC, Schaffner W, et al. (1998) Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A. Clin Infect Dis 27: 531-535.
15. Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, et al. (2007) Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 357: 1685-1694.
16. Taylor-Robinson DC, Regan M, Crowcroft N, Parry JV, Dardamissis E, (2007) Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom. Euro Surveill 12: E5-E6.
17. Belmaker I, Dukhan L, Yosef Y, Leventhal A, Dagan R, (2007) Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program. Pediatr Infect Dis J 26: 36-40.
18. Shen YG, Gu XJ, Zhou JH, (2008) Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community. World J Gastroenterol 14: 2771-2775.
19. Hauri AM, Fischer E, Fitzenberger J, Uphoff H, Koenig C, (2006) Active immunisation during an outbreak of hepatitis A in a German day-care centre. Vaccine 24: 5684-5689.
20. Torner N, Carnicer-Pont D, Castilla J, Cayla J, Godoy P, et al. (2011) Auditing the management of vaccine-preventable disease outbreaks: the need for a tool. PLoS One 6: e15699.